Related Experiment Videos
[Oncological complications after renal transplantation]
1Service de Néphrologie-Dialyse-Transplantation rénale, Hôpital Nord, CHU de Saint-Etienne, St-Priest en Jarez.
Presse Medicale (Paris, France : 1983)
|May 18, 1991
Summary
Renal transplant recipients face a significant risk of de novo tumors due to immunosuppression, with lymphoproliferative syndromes and Kaposi
Area of Science:
- Nephrology
- Oncology
- Immunology
Context:
- Renal transplantation is a life-saving procedure.
- Immunosuppression is critical for graft survival.
- Post-transplant oncological complications are a concern.
Purpose:
- To investigate the incidence and types of oncological complications in renal transplant recipients.
- To identify risk factors for de novo tumor development.
Summary:
- A study of 420 renal transplantations in 389 patients revealed de novo tumors in 26 recipients (induced by immunosuppression), leading to 7 deaths.
- Common de novo tumors included lymphoproliferative syndromes, Kaposi's sarcoma, and spinocellular epitheliomas.
- While excessive immunosuppression was implicated in one-third of cases, geographical/ethnic factors and herpes virus infections (in 76%) may also contribute to tumor development.
Impact:
- Highlights the need for careful immunosuppression management in renal transplant patients.
- Suggests further research into the role of viral infections and ethnic factors in post-transplant tumorigenesis.
- Informs clinical practice regarding cancer surveillance in renal transplant recipients.